Cutaneous adnexal tumor with an unusual presentation-discussion of a potential diagnostic pitfall

American Journal of Dermatopathology

Volumn 31, Issue 3, 2009, Pages 278-281

  Cangelosi, John J ^a   Nash, Jason W ^b   Prieto, Victor G ^b   Ivan, Doina ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adnexal tumor with ductal differentiation; Metastatic tumors to skin; P63

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; PROGESTERONE; PROTEIN P63; PROTEIN S 100; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2; TUMOR MARKER;

AGED; ANAMNESIS; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CELL DIFFERENTIATION; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EPITHELIOID CELL; ERYTHEMA; EXCISION; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; PRIMARY SKIN ADNEXAL CARCINOMA; PRIMARY TUMOR; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CARCINOMA; SKIN MANIFESTATION; SKIN METASTASIS; BIOPSY; BREAST TUMOR; CHEMISTRY; DIAGNOSTIC ERROR; IMMUNOHISTOCHEMISTRY; METASTASIS; PAGET NIPPLE DISEASE; PATHOLOGY; SECOND CANCER; SKIN TUMOR; SWEAT GLAND TUMOR;

AGED; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIFFERENTIATION; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, ADNEXAL AND SKIN APPENDAGE; NEOPLASMS, SECOND PRIMARY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 66149099617     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31819ddccf     Document Type: Article

References (19)

1. Ivan D, Nash JW, Prieto VG, et al. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. J Cutan Pathol. 2007;34:474-480.
2. Ivan D, Diwan AH, Prieto VG. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to skin. Mod Pathol. 2005;18:137-142.
3. Qureshi HS, Ormsby AH, Lee MW, et al. The diagnostic utility of p63, CK5/6, CK7, and CK20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol. 2004;31:145-152.
4. Wallace ML, Smoller BR. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin. Am J Dermatopathol. 1996;18:241-247.
5. Wallace ML, Longacre TA, Smoller BR. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms. Mod Pathol. 1995;8:897-901.
6. Flieder A, Koerner FC, Pilch BZ, et al. Endocrine mucin-producing sweat gland carcinoma: a cutaneous neoplasm analogous to solid papillary carcinoma of breast. Am J Surg Pathol. 1997;21:1501-1506.
7. Ormsby AH, Snow JL, Su WPD, et al. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein. J Am Acad Dermatol. 1995;32:711-716.
8. Kantrow SM, Ivan D, Williams MD, et al. Metastasizing adenocarcinoma and multiple neoplastic proliferations arising in a nevus sebaceus. Am J Dermatopathol. 2007;29:462-466.
9. Sariya D, Ruth K, Adams-McDonnell R, et al. Clinicopathologic correlation of cutaneous metastases: experience from a cancer center. Arch Dermatol. 2007;143:613-620.
10. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in normal and tumor tissues. Clin Cancer Res. 2002;8:494-501.
11. Signoretti S, Waltregny D, Dilks J, et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol. 2000;157: 1769-1775.
12. Reis-Filho JS, Simpson PT, Martins A, et al. Distribution of p63, cytokeratins 4/6 and cytokeratin 14 and 51 in normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch. 2003;443:122-132.
13. Wang BY, Gil J, Kaufman D, et al. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol. 2002;33:921-926.
14. Compérat E, Camparo P, Haus R, et al. Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases. Virchows Arch. 2006;448:319-324.
15. Barbareschi M, Pecciarini L, Cangi MG, et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol. 2001;25:1054-1060.
16. Stefanou D, Batistatou A, Nonni A, et al. p63 expression in benign and malignant breast lesions. Histol Histopathol. 2004;19:465-471.
17. Plumb SJ, Argenyi ZB, Stone MS, et al. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma. Am J Dermatopathol. 2004;26:447-451.
18. Ritter AM, Graham RS, Amaker B, et al. Intracranial extension of an eccrine porocarcinoma. Case report and review of the literature. J Neurosurg. 1999;90:138-140.
19. Affleck AG, Bong JL, Ostroumova MA, et al. Eccrine porocarcinoma. Dermatol Online J. 2006;12:17.